FdaApplication
ANDA 207523
Identifiers
- fda_app_no: ANDA207523
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2019-06-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE | EQ 2% BASE;EQ 0.5% BASE | SOLUTION/DROPS;OPHTHALMIC |
1 product